-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Fundamental Science, Clinical Research, Technology and Procedures
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Hall B (San Diego Convention Center)
Chair:
Olivier Elemento, PhD, MS, BS, Weill Cornell Medicine
Disclosures:
No relevant conflicts of interest to declare.
The session will address important and timely topics related to the application of artificial intelligence (AI) to hematology, ranging from generative AI's potential and pitfalls, modern ethical consideration for AI in biomedical research and examples of practical use of AI in hematology research and clinical care.

James Zou, PhD

Stanford University, Stanford, CA

Camille Nebeker, EdD

University of California San Diego, San Diego, CA

Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany